In this edition:
REMIX-1 & REMIX-2: remibrutinib in CSU
VANGUARD: garadacimab for hereditary angioedema prophylaxis in patients aged ≥65 years
Sitagliptin-induced angioedema without ACE inhibitor use
Primary aldosteronism with recurrent idiopathic angioedema
Anaphylaxis deaths in Australia 2003–23
Organ failure type in fatal anaphylaxis
Laryngoscopy after allergen challenge for laryngeal symptoms & low likelihood of anaphylaxis
Anaphylaxis in Australian schools 2016–24
Tri-a-14-specific IgE in recurrent idiopathic anaphylaxis
Please login below to download this issue (PDF)